EGFR-HER2 inhibitor CO-1686, Purity ≥98%

Cat. No.: X24-05-ZQ636

EGFR-HER2 inhibitor CO-1686, Purity ≥98%

Synonym: 1374640-70-6; CO1686; AVL-301; CNX-419; AVL 301; AVL301; CNX419; Rociletinib; AVL-301; EGFR-HER2 inhibitor

  • CAS Number: 1374640-70-6
  • Compound CID: 57335384
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
CO-1686, soluble in DMSO and insoluble in ethanol and water, is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR(L858R)/T790M and EGFRT790M.
Molecular Weight
555.55
Molecular Formula
C27H28F3N7O3
Targets
EGFR(L858R)/T790M: 21.5 nM (Ki); EGFRT790M: 303.3 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 91 mg/mL (163.8 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
CO-1686 can be used to study its efficacy as a mutant-selective EGFR inhibitor, especially in non-small cell lung cancer.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.